Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2.
Article Details
- CitationCopy to clipboard
Washburn WN
Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2.
J Med Chem. 2009 Apr 9;52(7):1785-94. doi: 10.1021/jm8013019.
- PubMed ID
- 19243175 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Binding Properties
Drug Target Property Measurement pH Temperature (°C) Dapagliflozin Sodium/glucose cotransporter 2 EC 50 (nM) 1.1 N/A N/A Details